# reload+after+2024-01-21 09:29:02.575489
address1§2711 Centerville Road
address2§Suite 400
city§Wilmington
state§DE
zip§19808
country§United States
phone§302 252 9160
website§https://www.enovis.com
industry§Specialty Industrial Machinery
sector§Industrials
longBusinessSummary§Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufacture and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
fullTimeEmployees§6800
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Matthew L. Trerotola', 'age': 56, 'title': 'CEO & Chairman', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 5119598, 'exercisedValue': 0, 'unexercisedValue': 1429539}, {'maxAge': 1, 'name': 'Mr. Brady R. Shirley', 'age': 57, 'title': 'President, COO & Director', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 3338514, 'exercisedValue': 0, 'unexercisedValue': 262297}, {'maxAge': 1, 'name': 'Ms. Patricia A. Lang', 'age': 64, 'title': 'Senior VP & Chief Human Resources Officer', 'yearBorn': 1959, 'fiscalYear': 2022, 'totalPay': 1590466, 'exercisedValue': 0, 'unexercisedValue': 56830}, {'maxAge': 1, 'name': 'Mr. Daniel A. Pryor', 'age': 55, 'title': 'Executive Vice President of Strategy & Business Development', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 2077362, 'exercisedValue': 641557, 'unexercisedValue': 485256}, {'maxAge': 1, 'name': 'Mr. Phillip Benjamin Berry', 'age': 44, 'title': 'Senior VP & CFO', 'yearBorn': 1979, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. John  Kleckner', 'age': 46, 'title': 'VP, Controller & Chief Accounting Officer', 'yearBorn': 1977, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Derek  Leckow', 'title': 'Vice President of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Bradley J. Tandy', 'age': 64, 'title': 'Senior VP & General Counsel', 'yearBorn': 1959, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Katie  Sweet', 'title': 'Vice President of Corporate Communication', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Terry  Ross', 'title': 'Group President Prevention & Recovery', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§4
boardRisk§2
compensationRisk§3
shareHolderRightsRisk§2
overallRisk§2
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§2.098
priceToSalesTrailing12Months§1.8476444
currency§USD
dateShortInterest§1702598400
forwardEps§2.66
pegRatio§1.12
exchange§NYQ
quoteType§EQUITY
shortName§Enovis Corporation
longName§Enovis Corporation
firstTradeDateEpochUtc§1210253400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§1ea9bec5-9b1b-359b-b676-99c8688f4d1d
gmtOffSetMilliseconds§-18000000
targetHighPrice§75.0
targetLowPrice§63.0
targetMeanPrice§70.5
targetMedianPrice§71.5
recommendationMean§1.7
recommendationKey§buy
numberOfAnalystOpinions§8
quickRatio§0.87
grossMargins§0.57813
ebitdaMargins§0.12042
trailingPegRatio§None
